Arthritis of Knee Clinical Trial
Official title:
A Prospective, Multicentre Study Evaluating the Clinical Performance of the ROCC Knee Prosthesis
| Verified date | March 2017 |
| Source | Zimmer Biomet |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This observational study intends to collect efficacy and safety data on ROCC Knee system.
| Status | Terminated |
| Enrollment | 200 |
| Est. completion date | December 2010 |
| Est. primary completion date | December 2010 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Patients suitable for Knee Replacement for: - osteoarthritis, - rheumatoid arthritis - bone necrosis affecting two knee compartments, - correction of genu varus, genu valgus or post-traumatic deformities, - sequelae of prior procedures. |
| Country | Name | City | State |
|---|---|---|---|
| Austria | A. ö Landeskrankenhaus Gmunden | Gmunden | |
| France | Clinique des Fontaines | Meulin | |
| Spain | Hospital Torrecardenas | Almeria |
| Lead Sponsor | Collaborator |
|---|---|
| Zimmer Biomet | Biomet France SARL |
Austria, France, Spain,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | American Knee Score | 3 months, 1yr, 2yr, 3yr, 4yr and 5 yr | ||
| Secondary | Complication | Any time | ||
| Secondary | Patient Satisfaction | 3 months, 1yr, 2yr, 3yr, 4yr and 5 yr |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02581605 -
Correction of Angular Deformities in Knee Arthrosis
|
||
| Completed |
NCT01505452 -
Study of Surgical Technique With Use of Single-radius Prosthesis in Total Knee Replacement
|
||
| Completed |
NCT00736138 -
Hyperpronation and Foot Pain
|
N/A | |
| Withdrawn |
NCT02294045 -
Analysis of Joint Sounds in the Diagnosis of Knee Disorders
|
||
| Completed |
NCT01873313 -
Blood Levels of Local Anaesthetic in Knee Arthroplasty
|
N/A | |
| Completed |
NCT01586312 -
Treatment of Knee Osteoarthritis With Allogenic Mesenchymal Stem Cells
|
Phase 1/Phase 2 |